Beacon Cancer Care ( Site 1599)

Summary

Beacon Cancer Care ( Site 1599) is a medical facility located in Post Falls, Idaho. This center is recognized for care of Parkinson's disease, Lung Cancer, Diffuse Large B-Cell Lymphoma, Head and Neck Cancers, Non-Small Cell Lung Cancer and other specialties. Beacon Cancer Care ( Site 1599) is involved with conducting 2 clinical trials across 6 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Beacon Cancer Care ( Site 1599)

Lung Cancer

Diffuse Large B-Cell Lymphoma

Parkinson's disease

Non-Small Cell Lung Cancer

V940 + Pembrolizumab

for Lung Cancer

This trial is testing a new treatment combination of V940 and pembrolizumab in patients who have had surgery to remove Stage II, IIIA, or IIIB non-small cell lung cancer. The goal is to see if this new combination can help prevent the cancer from coming back. V940 and pembrolizumab work together to help the immune system find and destroy any leftover cancer cells.

Recruiting

1 award

Phase 3

7 criteria

V940 + Pembrolizumab

for Non-Small Cell Lung Cancer

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment).

Recruiting

1 award

Phase 3

3 criteria